Estrogen receptor modulators

Details for Australian Patent Application No. 2004292555 (hide)

Owner Merck & Co., Inc.

Inventors Morgan, Jerry D. II; Blizzard, Timothy A.; Gude, Candido

Agent Spruson & Ferguson

Pub. Number AU-A-2004292555

PCT Pub. Number WO2005/051972

Priority 60/524,563 24.11.03 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/051972 Priority application(s): WO2005/051972

4 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292575-Method for treatment of a fluid quantity including chemical reacting means such as combustible materials and a catalytic device

2004292554-Anti-IGFR1 antibody therapeutic combinations